In this blog, we will look at some of the key challenges facing animal health manufacturers and...
5 minute read
Emerging pharmaceutical sectors to watch in 2023: Pyschedelics
Broughton CEO, Chris Allen, looks at the emerging field of psychedelic pharmaceutical drug development and shares some of the best articles he read in 2022.
Filter
Filter
Results - 33 Blogs
2 minute read
A Summary of DDL 2022
Day 1 of DDL opened with Federico Lavorini’s history and future of drug delivery, and it was a...
2 minute read
Learning from nicotine: using the advances in nicotine delivery to revolutionize inhalation therapy
Smoking is one of the most efficient and effective methods of delivering a drug to the lungs; which...
3 minute read
Broughton shares the highlights from RDD 2022
Broughton's Toxicology Managing Consultant Dr. Tony Jones summarizes the highlights and key...
2 minute read
Pharmacovigilance - Artificial Intelligence and lessons learned from the pandemic.
Broughton's Head of Regulatory Affairs, Lloyd Smart, and Technical Sales Administrator, Curtis...
2 minute read
Consultation on Proposals for the Future of UK Clinical Trial Legislation
Broughton's Head of Regulatory Affairs, Lloyd Smart, has recently published an article with the...
2 minute read
Broughton collaborates with leading global pharmaceutical experts at DDL
Broughton's Director of Product Development Services, Dr Fozia Saleem, and Technical Sales...
Broughton's Chief Scientific Officer, Chris Allen, and Technical Sales Administrator, Curtis...
Broughton Chief Regulatory Officer, Dr Nveed Chaudhary announces the launch of our Blue-sky...
Sign up to our newsletter
Ensure your business stays ahead of the competition by keeping up to date on the latest regulatory changes. Sign up for our newsletter to have the latest information and insights served directly to your inbox.